TVM Capital Life Science raised $8 million to invest in myo

Mar 5, 2024

TVM Capital Life Science, a venture capital firm specializing in life sciences and healthcare, raised $8 million to invest in myo, a company developing an innovative, easy-to-use app aimed at revolutionizing elderly care. (Published by GlobeNewswire)

Great! Next, complete checkout for full access to Agetech News.
Welcome back! You've successfully signed in.
You've successfully subscribed to Agetech News.
Success! Your account is fully activated, you now have access to all content.
Success! Your billing info has been updated.
Your billing was not updated.